Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mycophenolate mofetil beneficial for systemic sclerosis

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Mycophenolate mofetil beneficial for systemic sclerosis. Inpharma Wkly. 1586, 12 (2007). https://doi.org/10.1007/BF03272625

    Download citation

    Keywords

    • Adverse Event
    • Survival Rate
    • Retrospective Analysis
    • Therapeutic Option
    • Disease Onset